Health technology blooms in Magdeburg
The city of Magdeburg in eastern Germany, just a 90-minute drive from Berlin, is facing momentous change. In recent years, the capital of Saxony-Anhalt has blossomed into a healthtech hotspot. Several dozen healthtech and pharmaceutical companies have settled there – including some notable international players. One example is Salutas Pharma, a division of the Novartis group, which is now a major employer in the region and one of many companies from abroad capitalizing on the growing opportunities in the healthtech cluster.
One of the major attractions of Magdeburg is the presence of a Max Planck Institute and a network of research centers. Already in 2018, for example, the institute launched a technology that vastly accelerates the production of virus vaccines. In a world that is adapting to coronavirus, having access to that kind of expertise is a distinct advantage for healthcare firms.